Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Convergent Therapeutics Secures $90M Series A Financing

2023-05-03
CAMBRIDGE, MA, Convergent Therapeutics announces a $90M Series A financing led by OrbiMed and RA Capital Management.
Convergent Therapeutics, a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, announced the completion of a $90 million Series A financing, led by OrbiMed and RA Capital Management with participation from Invus. The financing will support the development of a pipeline of novel radioantibodies, including its lead program with CONV01-α, for the treatment of advanced prostate cancer.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors